Shanghai Haohai Biological Technology Co. Ltd (5HB) — Cash Flow Quality Index
Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Cash Flow Quality Index of 1.38x as of June 2023. Operating cash flow of €141.99 Million exceeds net income of €102.62 Million, indicating high earnings quality where cash backs reported profits. Also explore Shanghai Haohai Biological Technology Co assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Haohai Biological Technology Co. Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Shanghai Haohai Biological Technology Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shanghai Haohai Biological Technology Co (5HB) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shanghai Haohai Biological Technology Co. Ltd (2016–2024)
Year-by-year earnings quality comparison for Shanghai Haohai Biological Technology Co. Ltd. For live market cap and the full company financial profile, see Shanghai Haohai Biological Technology Co (5HB) market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.54x | €648.57 Million | €420.45 Million | ▲ +1.2% |
| 2023 | 1.52x | €634.45 Million | €416.12 Million | ▲ +19.0% |
| 2022 | 1.28x | €231.30 Million | €180.47 Million | ▲ +32.0% |
| 2021 | 0.97x | €342.29 Million | €352.45 Million | ▼ -14.7% |
| 2020 | 1.14x | €262.07 Million | €230.07 Million | ▲ +21.0% |
| 2019 | 0.94x | €348.91 Million | €370.78 Million | ▼ -0.3% |
| 2018 | 0.94x | €391.28 Million | €414.54 Million | ▲ +2.5% |
| 2017 | 0.92x | €343.06 Million | €372.42 Million | ▲ +10.4% |
| 2016 | 0.83x | €254.49 Million | €305.05 Million | — |